N159S mutations were associated with aberrant karyotype, significantly higher rates of myelodysplasia‐related gene mutations, ELN2022 adverse risk and a particularly poor outcome, supporting the classification of IKZF1 N159S‐mutated AML as a rare molecular subtype with adverse prognosis. The gene discussed is IKZF1; the disease is acute myeloid leukemia.